Assistência perioperatória de paciente com infecção pelo SARS‐CoV‐2 (COVID‐19) submetido a ressecção de tumor de hipófise urgente. Relato de caso e diretrizes para manejo de via aérea

Santos, Christiano Dos Santos E; Filho, L Moreira; Santos, Cristiane Araujo Tuma; Neill, James S.; Vale, Henrique; Kurnutala, Lakshmi N

doi:10.1016/j.bjan.2020.06.001

Cited by 14 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Altogether 15 articles meeting the search criteria were included ( Table 1 ). 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 These 15 articles reported altogether 17 patients, 10 males and seven females. Age of these patients ranged from 20 to 75y ( Table 1 ).…”

Section: Resultsmentioning

confidence: 99%

The pituitary gland in SARS-CoV-2 infections, vaccinations, and post-COVID syndrome

Finsterer¹

2023

Clinics

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

The pituitary gland in SARS-CoV-2 infections, vaccinations, and post-COVID syndrome

Finsterer¹

2023

Clinics

View full text Add to dashboard Cite

“…The infection caused by the new coronavirus is highly contagious and can cause asymptomatic conditions or even more extreme situations, such as Severe Acute Respiratory Syndrome (SARS) and death (Santos et al, 2020). SARS, in turn, is defined as the worsening of an individual with an acute respiratory condition, in which, regardless of age, the person may show signs and symptoms such as: difficulty breathing, sore throat, myalgia, dyspnoea or less than oxygen saturation 95% (Silveira et al, 2020).…”

Section: Introductionmentioning

confidence: 99%

Epidemiology of Severe Acute Respiratory Syndrome (Sars) Caused by Covid-19 in the State of Bahia

Ferreira¹,

Silva

et al. 2020

HOLOS

View full text Add to dashboard Cite

show abstract

Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era

Boyke,

Michel,

Mamelak

2024

Pituitary

View full text Add to dashboard Cite

Pituitary apoplexy (PA) is a clinical syndrome caused by acute hemorrhage and/or infarction of the pituitary gland, most commonly in the setting of a pituitary macroadenoma. PA generally presents with severe headache, nausea, vomiting, visual disturbance, and, in more severe cases, altered mental status. Many factors have been attributed to the risk of developing PA, including most recently, numerous reports showcasing an association with COVID-19 infection or vaccination. Initial management of PA includes evaluation and correction of deficient hormones and electrolytes and an assessment if surgical decompression to relieve pressure on optic nerves and other brain structures is needed. While prompt recognition and treatment are crucial to avoid morbidity and mortality, in the modern era, PA is less commonly considered a true neurosurgical emergency requiring immediate (< 24 h) surgical decompression. Traditionally, surgical decompression has been the standard of care for significant mass effects. However, several studies have shown similar outcomes in visual and hormonal recovery with either surgical decompression or conservative medical management. Unfortunately, most evidence on optimal management strategies is limited to retrospective case series, small prospective studies, and one multi-center observational study. This review aims to provide the most up-to-date evidence on the role of COVID-19 in PA and best management strategies.

show abstract

Assistência perioperatória de paciente com infecção pelo SARS‐CoV‐2 (COVID‐19) submetido a ressecção de tumor de hipófise urgente. Relato de caso e diretrizes para manejo de via aérea

Cited by 14 publications

References 9 publications

The pituitary gland in SARS-CoV-2 infections, vaccinations, and post-COVID syndrome

The pituitary gland in SARS-CoV-2 infections, vaccinations, and post-COVID syndrome

Epidemiology of Severe Acute Respiratory Syndrome (Sars) Caused by Covid-19 in the State of Bahia

Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era

Contact Info

Product

Resources

About